Abstract
Background: Risk factors of drug-induced nephrotoxicity include drug overdose, drug-drug interactions and drug-related adverse effects. Since the usage of some nephrotoxic drugs is still unavoidable in the clinical setting, understanding the pathogenic mechanisms of their nephrotoxicities is critical to decrease the incidence of kidney injury. Early detection of drug-induced nephrotoxicity and reduction of the therapeutic side effects are realistic approaches to avoid the end stage of renal failure.
Method: In this review, we summarized the mechanisms and prevention strategies for some drugs that were commonly used clinically and had the possibility of inducing acute and chronic kidney injuries. We discussed the advantages and drawbacks of currently available biomarkers for indicating kidney impairment. In vitro and pre-clinical in vivo models for assessing the nephrotoxicity during the drug developmental stages were also evaluated.
Results: Nowadays, an increasing number of biomarkers were discovered for the early diagnosis of kidney injury. In addition, various kinds of in vitro and pre-clinical in vivo models were developed and utilized to minimize the potential nephrotoxicity during the drug development.
Conclusion: The discovery of the early biomarkers and development of accurate diagnostic methods are effective prevention strategies for drug-induced kidney impairment.
Keywords: Drug-induced nephrotoxicity, acute kidney injury (AKI), chronic kidney disease (CKD), kidney function, biomarkers, early diagnosis.
Current Drug Metabolism
Title:Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies
Volume: 19 Issue: 7
Author(s): Huizi Wu*Jiaguo Huang*
Affiliation:
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008,China
- Medical Research Center, Medical Faculty Mannheim, University of Heidelberg, Mannheim,Germany
Keywords: Drug-induced nephrotoxicity, acute kidney injury (AKI), chronic kidney disease (CKD), kidney function, biomarkers, early diagnosis.
Abstract: Background: Risk factors of drug-induced nephrotoxicity include drug overdose, drug-drug interactions and drug-related adverse effects. Since the usage of some nephrotoxic drugs is still unavoidable in the clinical setting, understanding the pathogenic mechanisms of their nephrotoxicities is critical to decrease the incidence of kidney injury. Early detection of drug-induced nephrotoxicity and reduction of the therapeutic side effects are realistic approaches to avoid the end stage of renal failure.
Method: In this review, we summarized the mechanisms and prevention strategies for some drugs that were commonly used clinically and had the possibility of inducing acute and chronic kidney injuries. We discussed the advantages and drawbacks of currently available biomarkers for indicating kidney impairment. In vitro and pre-clinical in vivo models for assessing the nephrotoxicity during the drug developmental stages were also evaluated.
Results: Nowadays, an increasing number of biomarkers were discovered for the early diagnosis of kidney injury. In addition, various kinds of in vitro and pre-clinical in vivo models were developed and utilized to minimize the potential nephrotoxicity during the drug development.
Conclusion: The discovery of the early biomarkers and development of accurate diagnostic methods are effective prevention strategies for drug-induced kidney impairment.
Export Options
About this article
Cite this article as:
Wu Huizi *, Huang Jiaguo *, Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies, Current Drug Metabolism 2018; 19 (7) . https://dx.doi.org/10.2174/1389200218666171108154419
DOI https://dx.doi.org/10.2174/1389200218666171108154419 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Impact of brain tissue binding and plasma protein binding of drugs in DMPK
The impression of brain tissue binding (BTB) or plasma protein binding (PPB) in Drug Metabolism and Pharmacokinetics is critical to understanding the distribution, efficacy, and potential toxicity of drugs that target the central nervous system (CNS). BTB and high PPB influence the distribution of drugs in the body and their ...read more
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Metabolism-Mediated Xenobiotic Toxicity
Considering the potent modulation of biotransformation enzyme expression and activities by various therapeutic drugs and environmental chemicals, and the commonly combined exposure of humans to both drugs and the ever increasing environmental pollutants simultaneously, knowledge about the combined toxic effects by modulating biotransformation enzymes, such as P450s, UDP- glucuronosyltransferases, and ...read more
Safety evaluation of vaccine combination
Vaccine combination safety evaluation is a critical field within immunology and public health that focuses on assessing the safety and efficacy of combining different vaccines to maximize protection against various diseases while minimizing potential adverse effects. This process is significant because it ensures that vaccines can be administered together without ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC
Current Cancer Drug Targets Morpholino, siRNA, and S-DNA Compared: Impact of Structure and Mechanism of Action on Off-Target Effects and Sequence Specificity
Current Topics in Medicinal Chemistry The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunates Activity in Cancer Cells
Current Cancer Drug Targets Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism Synthetic Peptides Derived from the C-Terminal Region of Lys49 Phospholipase A2 Homologues from Viperidae Snake Venoms: Biomimetic Activities and Potential Applications
Current Pharmaceutical Design Preparation and Antitumor Effect of N-Trimethylchitosan/Fucoidan Ion-Complex Submicron Particles
Current Nanoscience Anticancer Activity of the Ascidian Polyclinum Indicum against Cervical Cancer Cells (HeLa) Mediated through Apoptosis Induction
Medicinal Chemistry Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases
Current Topics in Medicinal Chemistry Biologically Active Phytochemicals: A Brief Appraisal
Current Traditional Medicine Dynamics of Virus-Host Interplay in HIV-1 Replication
Current HIV Research Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Comparison of Physicochemical Properties of Generic Doxorubicin HCl Liposome Injection with the Reference Listed Drug
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Properties of Indazole Derivatives: Recent Developments
Mini-Reviews in Medicinal Chemistry Pharmacological Interventions for the Prevention and Treatment of Kidney Injury Induced by Radiotherapy: Molecular Mechanisms and Clinical Perspectives
Current Molecular Pharmacology Nucleic Acids as Therapeutic Agents
Current Topics in Medicinal Chemistry Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future
Current Molecular Medicine The AICD Interacting Protein DAB1 is Up-Regulated in Alzheimer Frontal Cortex Brain Samples and Causes Deregulation of Proteins Involved in Gene Expression Changes
Current Alzheimer Research Role of the RAS in Pancreatic Cancer
Current Cancer Drug Targets Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
Current Topics in Medicinal Chemistry Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer
Current Pharmaceutical Design